CAS No. |
1018448-65-1 |
|---|---|
中文名称 |
[(14S,16S,32S,33R,2R,4S,10Z,12Z,14R)-86-氯-14-羟基-85,14-二甲氧基-33,2,7,10-四甲基-12,6-二氧代-7-氮杂-1(6,4)-氧氮杂环烷-3(2,3)-环氧烷-8(1,3)-苯并环十四烷二烯-4-基]N-(3-[(1-((4-氨甲酰基环己基)甲基)-2,5-二氧代吡咯烷-3-基)硫基]丙酰基)-N-甲基-L-丙氨酸酯 |
英文名称 |
(14S,16S,32S,33R,2R,4S,10Z,12Z,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-((1-((4-carbamoylcyclohexyl)methyl)-2,5-dioxopyrrolidin-3-yl)thio)propanoyl)-N-methyl-L-alaninate |
别名 |
Ado-trastuzuMab-eMtansine cas nr;trastuzumab emtansine;Ado-trastuzumab emtansine;Ado-trastuzumab Emtansine (TDM-1);Kadcyla;PRO132365;T-DM1;trastuzumab-DM1 |
标准英文名 |
(14S,16S,32S,33R,2R,4S,10Z,12Z,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(3-((1-((4-carbamoylcyclohexyl)methyl)-2,5-dioxopyrrolidin-3-yl)thio)propanoyl)-N-methyl-L-alaninate |
分子式 |
C47H64ClN5O13S |
分子量 |
974.57 |
精确分子量 |
973.39 |
SMILES |
COC1=CC2=CC(=C1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSC1CC(=O)N(CC3CCC(C(N)=O)CC3)C1=O)[C@@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C\C=C(\C)C2 |
标准SMILES |
C[C@]12O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@@H](C=CC=C(C)CC1C=C(OC)C(Cl)=C(C=1)N(C)C(=O)C[C@@H]2OC(=O)[C@H](C)N(C)C(=O)CCSC1CC(=O)N(CC2CCC(CC2)C(N)=O)C1=O)OC |
用途 |
Trastuzumab emtansine is used for the treatment of advanced breast cancer; it significantly inhibits the proliferation of epithelial ovarian cancer (EOC) cells in vitro; it exhibits significant anti-tumor effects in vivo, showing remarkable inhibition of tumor growth in mice bearing OVA10 cells and is well tolerated. |
InChIKey |
WPWQMVXPTHKASL-NVDAOWMUSA-N |
|
|
评论 |
|---|